Investigation Report on China's Loratadine Market, 2018-2022

Publisher Name :
Date: 13-Dec-2018
No. of pages: 30

Description

The incidences of common skin redness, itching and rashes and respiratory allergies are rising as China's economy develops, the living environment and dietary structure change, and environmental pollution intensifies, which drives the growth of the antihistamine market.

As a second-generation antihistamine, Loratadine is a common H1 receptor antagonist used to relieve the symptoms of allergic rhinitis, eye itching and burning sensation, and the symptoms and signs of chronic urticaria, pruritic skin diseases and other allergic skin diseases. It can quickly relieve nose and eye allergies. Moreover, Loratadine has a low affinity for the H1 receptor of the central nervous system, and thus has hardly any side effect on the nervous system.

Developed by Schering-Plough which has been acquired by Bayer, Loratadine (trade name: Clarityne) was first launched in Belgium in 1988 and then sold in several European countries. In Apr. 1993, it was approved by the FDA to be marketed in the U.S. In Sept. 2002, it was launched in Japan. In November of the same year, the FDA approved Clarityne as a non-prescription drug.

In Jun. 1993, imported Loratadine tablets were approved to be sold in China under the trade name Clarityne. In 2005, the CFDA approved Clarityne as a non-prescription drug for its excellent effect and long-tested safety. Many Chinese companies have launched generic Loratadine products in the dosage forms of oral tablets, capsules, granules, syrup and compound preparation. The market competition is fierce but the brand-name drug still has great advantages. In 2017, Shanghai Schering-Plough Pharmaceutical Co., Ltd. and Schering-Plough occupied about 65% market share by sales value. But the market share of the brand-name drug showed a downward trend.

Loratadine has secured a place on the market by advantage of long-lasting and quick-acting effect and rare adverse reactions. However, with the increasing number of Loratadine manufacturers and intensifying competition on the market, the average price of Loratadine is declining.

It is expected that as the incidences of allergic diseases continue to increase, China's Loratadine market will still have some growth potential in the next few years.

Topics Covered:

- Situation of allergic diseases in China

- Status of China's Loratadine market

- Competition on China's Loratadine market

- Prices of Loratadine in China

- Major factors influencing development of China's Loratadine market

- Prospect of China's Loratadine market from 2018 to 2022

Investigation Report on China's Loratadine Market, 2018-2022

Table of Contents
1 Relevant Concepts of Loratadine
1.1 Indications for Loratadine
1.2 Development of Loratadine in China
1.3 Governmental Approval of Loratadine in China

2 Sales of Loratadine in China, 2013-2017
2.1 Sales Value of Loratadine in China
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Loratadine
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Loratadine by Dosage Form in China, 2013-2017
2.3.1 Sales of Loratadine Tablets in China
2.3.2 Sales of Loratadine Capsules in China
2.3.3 Sales of Loratadine Granules in China
2.3.4 Sales of Loratadine Syrups in China

3 Analysis on Major Loratadine Manufacturers in China, 2013-2017
3.1 Analysis on Market Shares of Major Loratadine Manufacturers in China
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Shanghai Schering-Plough Pharmaceutical Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of Shanghai Schering-Plough Pharmaceutical Co., Ltd.'s Loratadine in China
3.3 Schering-Plough
3.3.1 Enterprise Profile
3.3.2 Sales of Schering Plough's Loratadine in China
3.4 Beijing SL Pharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Beijing SL Pharmaceutical Co., Ltd.'s Loratadine in China
3.5 Venturepharm Pharmaceutical (Hainan) Co., Ltd.
3.6 Jiangsu Hanchen Pharmaceutical Co., Ltd.

4 Prices of Loratadine in China, 2017-2018
4.1 Shanghai Schering-Plough Pharmaceutical Co., Ltd. (Clarityne)
4.2 Schering-Plough (Clarityne)
4.3 Beijing SL Pharmaceutical Co., Ltd. (Leining)
4.4 Venturepharm Pharmaceutical Co., Ltd. (Baiweile)
4.5 Jiangsu Hanchen Pharmaceutical Co., Ltd. (Yibaizhi)

5 Prospect of China's Loratadine Market, 2018-2022
5.1 Major Factors Influencing Development of China's Loratadine Market
5.1.1 Favorable Factors
5.1.2 Unfavorable Factors
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

List of Charts
Chart Governmental Approval of Loratadine in China
Chart Sales Value of Loratadine in China, 2013-2017
Chart Sales Value of Loratadine in Parts of China, 2013-2017
Chart Sales Volume of Loratadine in China, 2013-2017
Chart Sales Volume of Loratadine in Parts of China, 2013-2017
Chart Sales Value of Loratadine Tablets in China, 2013-2017
Chart Sales Volume of Loratadine Tablets in China, 2013-2017
Chart Sales Value of Loratadine Capsules in China, 2013-2017
Chart Sales Value of Loratadine Granules in China, 2013-2017
Chart Market Share of Top 5 Loratadine Manufacturers by Sales Value in China, 2013-2017
Chart Profile of Shanghai Schering-Plough Pharmaceutical Co., Ltd.
Chart Sales Value of Shanghai Schering-Plough Pharmaceutical Co., Ltd.'s Loratadine, 2013-2017
Chart Profile of Schering-Plough
Chart Sales Value of Schering-Plough's Loratadine in China, 2013-2017
Chart Sales Volume of Schering-Plough's Loratadine in China, 2013-2017
Chart Profile of Beijing SL Pharmaceutical Co., Ltd.
Chart Sales Value of Beijing SL Pharmaceutical Co., Ltd.'s Loratadine, 2013-2017
Chart Sales Value of Venturepharm Pharmaceutical (Hainan) Co., Ltd.'s Loratadine, 2013-2017
Chart Sales Value of Jiangsu Hanchen Pharmaceutical Co., Ltd.'s Loratadine, 2013-2017
Chart Prices of Shanghai Schering-Plough Pharmaceutical Co., Ltd.'s Loratadine (Clarityne) in Parts of China, 2017-2018
Chart Prices of Schering-Plough's Loratadine (Clarityne) in Parts of China, 2017-2018
Chart Prices of Beijing SL Pharmaceutical Co., Ltd.'s Loratadine (Leining) in Parts of China, 2017-2018
Chart Prices of Venturepharm Pharmaceutical (Hainan) Co., Ltd.'s Loratadine (Baiweile) in Parts of China, 2017-2018
Chart Prices of Jiangsu Hanchen Pharmaceutical Co., Ltd.'s Loratadine (Yibaizhi) in Parts of China, 2017-2018
Chart Forecast on Sales Value of Loratadine in China, 2018-2022

  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs